comparemela.com

Latest Breaking News On - Cullinan oncology - Page 12 : comparemela.com

DelveInsight Business Research, LLP: A Comprehensive Analysis of the Chemotherapy-induced Complications Market Outlook by 2032

DelveInsight Business Research, LLP: A Comprehensive Analysis of the Chemotherapy-induced Complications Market Outlook by 2032
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Shruti-thakur
Halneuron-tetrodotoxin
Bristol-myers-squibb
Zydus-cadila
Johnson-janssen
Roche-genentech
Heidelberg-pharma
Asahi-kasei
Abbvie-teneoone
Daiichi-sankyo
Redcloud-bio
Genelux-corporation

A Comprehensive Analysis of the Chemotherapy-induced Complications Market Outlook by 2032

/PRNewswire/ Chemotherapy is a systemic treatment that uses drugs to target and destroy cancer cells throughout the body. It can be administered in various.

Heidelberg-pharma
Roche-genentech
Johnson-janssen
Redcloud-bio
Shruti-thakur
Daiichi-sankyo
Halneuron-tetrodotoxin
Zydus-cadila
Bristol-myers-squibb
Asahi-kasei
Abbvie-teneoone
Xiamen-lp-pharmaceutical-co-ltd

Cullinan Oncology, Inc. (NASDAQ:CGEM) Sees Large Drop in Short Interest

Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) was the recipient of a large decline in short interest in the month of September. As of September 15th, there was short interest totalling 2,180,000 shares, a decline of 17.7% from the August 31st total of 2,650,000 shares. Based on an average trading volume of 189,900 shares, […]

United-states
California
Cullinan-oncology-inc
Pricet-rowe-associates-inc
Cullinan-oncology-company-profile
Nasdaq
Nuveen-asset-management
Cullinan-oncology
Get-free-report
Oncology-stock-down
Asset-management

EcoR1 Capital LLC Sells 788,628 Shares of Cullinan Oncology, Inc. (NASDAQ:CGEM)

EcoR1 Capital LLC cut its stake in shares of Cullinan Oncology, Inc. (NASDAQ:CGEM – Free Report) by 76.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 246,410 shares of the company’s stock after selling 788,628 shares during the quarter. EcoR1 […]

United-states
America
Deutsche-bank
America-corp
Exchange-commission
Cullinan-oncology-inc
Nasdaq
Franklin-resources-inc
Cullinan-oncology
Free-report
Get-free-report

EcoR1 Capital LLC Decreases Stake in Cullinan Oncology, Inc. (NASDAQ:CGEM)

EcoR1 Capital LLC cut its holdings in Cullinan Oncology, Inc. (NASDAQ:CGEM – Free Report) by 76.2% during the first quarter, Holdings Channel reports. The institutional investor owned 246,410 shares of the company’s stock after selling 788,628 shares during the quarter. EcoR1 Capital LLC’s holdings in Cullinan Oncology were worth $2,521,000 at the end of the […]

United-states
America
Deutsche-bank
America-corp
Holdings-channel
Nasdaq
Franklin-resources-inc
Cullinan-oncology-inc
Cullinan-oncology
Free-report
Get-free-report

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.